861. Development and Clinical Validation of a Custom Modified Two-Tier Testing Algorithm for Serodiagnosis of Lyme Disease

Michelle Gaylord(Pfizer (United States)), Warren V. Kalina(Pfizer (United States)), Annaliesa S. Anderson(Pfizer (United States)), Danielle Baranova(Pfizer (United States)), Raphael Simon(University of Maryland, Baltimore), Michael W. Pride(Pfizer (United States))
Open Forum Infectious Diseases
November 27, 2023
10.1093/ofid/ofad500.906
Cited by 0

Related Papers

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
|New England Journal of Medicine|2020|15.7k
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
|Nature|2020|2.1k
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
|Nature|2020|1.6k
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
|New England Journal of Medicine|2015|1.2k